Clinical Significance of Regulatory T Cells in Regional Lymph Node Lymphocytes of Non-Small-Cell Lung Cancer and overcoming immune-escape mechanism
Clinical Significance of Regulatory T Cells in Regional Lymph Node Lymphocytes of Non-Small-Cell Lung Cancer and overcoming immune-escape mechanism
批准号:
23592079
负责人:
HANAGIRI Takeshi
金额:
$3.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013
中文摘要
调节性T细胞(Tregs)是一种有效的免疫抑制细胞,在肿瘤免疫逃逸中起着至关重要的作用。本研究的目的是评估非小细胞肺癌(NSCLC)手术切除患者区域淋巴结淋巴细胞(RLNL)中CD4+ CD25+ Foxp3+ Tregs的预后意义。流式细胞术和定量RT-PCR检测RLNL中Tregs的比例。Tregs比例低的患者5年生存率明显高于Tregs比例高的患者。在非小细胞肺癌中,RLNL中较高比例的treg是一个重要的不利预后因素。RLNL中Tregs的比例信息对于克服肿瘤免疫逃逸,开发有效的辅助免疫治疗具有重要意义
英文摘要
Regulatory T cells (Tregs) are potent immunosuppressive cells that play a crucial role in tumor immune escape. The purpose of the present study was to evaluate the prognostic significance of CD4+ CD25+ Foxp3+ Tregs in the regional lymph node lymphocytes (RLNL) in patients who underwent surgical resection of non-small cell lung cancer (NSCLC). The proportions of Tregs in the RLNL were determined by flow cytometry and quantitative RT–PCR. The 5-year survival rate was significantly better in patients with the lower proportion of Tregs than that in the higher patients. The higher proportion of Tregs in the RLNL was a significant unfavorable prognostic factor in NSCLC. The information about the proportion of Tregs in the RLNL is considered to be important to overcome the tumor immune escape for development of the effective adjuvant immunotherapy
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.jss.2012.07.029
发表时间:
2013-05-15
期刊:
JOURNAL OF SURGICAL RESEARCH
影响因子:
2.2
作者:
[Hanagiri, Takeshi, Shigematsu, Yoshiki, Tanaka, Fumihiro]
通讯作者:
Tanaka, Fumihiro
Establishment of novel treatment strategy based on the biological characteristics of esophageal squamous cell carcinoma.
-
批准号:20591582
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2008
-
负责人:HANAGIRI Takeshi
-
依托单位:
Malignant mesothelioma associated antigens recognized by tumor infiltrating B cells. -usefulness of antibody titer to the antigens -
-
批准号:18591570
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.44万
-
财政年份:2006
-
负责人:HANAGIRI Takeshi
-
依托单位:
海外基金